Karas Eric (CIK 0001951287)

Latest company ownership

SPRY - ARS Pharmaceuticals, Inc.

Role: Chief Commercial Officer

Shares held

15,000

Last filed at

Jul 3, 2025

Confidence Score

40.1

2025Q4

Confidence Score History

2024Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jul 1, 2025	Jul 3, 2025	ARS Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	7.5	-15,000	-59.25%	✓	$254.9K
Jun 18, 2025	Jun 20, 2025	ARS Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	10.0	-15,000	-66.09%	✓	$240K
Mar 20, 2025	Mar 21, 2025	ARS Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	10.0	-10,000	-56.51%	✓	$140K
Dec 2, 2024	Dec 4, 2024	ARS Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	10.0	-10,000	-46.76%	✓	$140.4K
Sep 18, 2024	Sep 19, 2024	ARS Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	10.0	-10,000	-63.72%	✓	$140K
Aug 19, 2024	Aug 21, 2024	ARS Pharmaceuticals, Inc.	Chief Commercial Officer	Sell	10.0	-10,000	-63.72%	✓	$140K